Shelter Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	52.8	34.2	50.4	4.29	1	3.71
Cash & Short-Term Investments	52.8	34.2	50.4	4.29	1	3.71
Cash Growth	-11.97%	-32.14%	1076.13%	328.07%	-72.98%	166.93%
Accounts Receivable	109.36	94.75	88.5	81.95	16.06	7.6
Other Receivables	-	-	-	-	0.84	0.66
Receivables	186.76	94.75	88.5	81.95	16.89	8.26
Inventory	167.48	128.95	99.29	79.65	56.74	40.15
Prepaid Expenses	-	-	0	0.01	0.01	-
Other Current Assets	15.78	74.89	59	21.27	23.68	26.67
Total Current Assets	422.81	332.79	297.19	187.16	98.32	78.78
Property, Plant & Equipment	68.06	59.51	35.71	18.45	20.05	15.69
Long-Term Investments	6.76	0.01	0.01	0.01	0.01	-
Other Intangible Assets	0.1	0.1	0.09	-	-	-
Long-Term Deferred Tax Assets	0.44	0.32	0.36	-	-	-
Other Long-Term Assets	170.79	90.63	45.81	8.87	10.02	7.55
Total Assets	668.95	483.36	379.15	214.48	128.39	102.02
Accounts Payable	7.95	12.51	7.14	4.68	3.23	3.12
Accrued Expenses	-	1.75	1.25	0.73	0.05	0.14
Short-Term Debt	3.77	1.13	0.04	13.04	0.38	0.05
Current Portion of Long-Term Debt	-	-	-	-	0.29	-
Current Income Taxes Payable	-	30.02	5.66	17.79	6.5	0.02
Current Unearned Revenue	-	-	-	25	-	-
Other Current Liabilities	41.43	0.88	0.66	1.24	26.63	25.24
Total Current Liabilities	53.15	46.29	14.75	62.48	37.07	28.56
Long-Term Debt	8.43	9.32	5.73	4.8	0.65	-
Pension & Post-Retirement Benefits	0.55	0.55	0.51	0.49	0.38	0.88
Long-Term Deferred Tax Liabilities	-	-	-	1.23	1.01	1
Other Long-Term Liabilities	-0	-0	-0	-0	-0	-0
Total Liabilities	62.13	56.15	20.99	69	39.11	30.44
Common Stock	115.6	115.6	115.6	77.44	4.84	4.84
Additional Paid-In Capital	-	122.11	122.11	39.96	39.96	39.96
Retained Earnings	-	180.08	111.03	18.67	35.07	17.36
Comprehensive Income & Other	491.23	9.42	9.42	9.42	9.42	9.42
Shareholders' Equity	606.83	427.21	358.16	145.49	89.29	71.58
Total Liabilities & Equity	668.95	483.36	379.15	214.48	128.39	102.02
Total Debt	12.2	10.44	5.77	17.84	1.31	0.05
Net Cash (Debt)	40.6	23.76	44.62	-13.56	-0.31	3.66
Net Cash Growth	-16.81%	-46.76%	-	-	-	-
Net Cash Per Share	2.54	2.06	3.86	-1.75	-0.04	0.49
Filing Date Shares Outstanding	11.57	11.56	11.56	11.56	7.74	7.74
Total Common Shares Outstanding	11.57	11.56	11.56	7.74	7.74	7.74
Working Capital	369.66	286.5	282.44	124.68	61.25	50.22
Book Value Per Share	52.45	36.96	30.98	18.79	11.53	9.24
Tangible Book Value	606.73	427.11	358.07	145.49	89.29	71.58
Tangible Book Value Per Share	52.44	36.95	30.98	18.79	11.53	9.24
Buildings	-	-	40.19	30.69	25.14	24.65
Machinery	-	-	10.58	6.56	6.52	6.5
Construction In Progress	-	-	6.18	-	5.55	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.